Ubie, a New York-based AI-driven and medically vetted healthcare prediction platform, has secured over $125 million in total funding.
Investors
Backers include Google, JAPAN POST CAPITAL, NTT DOCOMO, SEVEN-ELEVEN JAPAN, Japan Finance Corporation, and The Shoko Chukin Bank.
Ubie Use of Funds
The funding will support Ubie’s U.S. expansion, the development of generative AI for patient education, and the continued refinement of its provider-focused solutions in partnership with the Mayo Clinic.
About Ubie
Founded in 2017, Ubie is a global healthtech company offering AI-powered tools that help patients navigate healthcare systems and access timely, appropriate care. Its flagship product, the Ubie AI Symptom Checker, is a medically vetted platform that guides users to appropriate care pathways using advanced predictive models. Leveraging cutting-edge disease prediction AI, Ubie helps patients seek appropriate medical attention through its free online Symptom Checker. Founded in 2017, Ubie supports over 1,800 provider organizations.
Funding Details
Company: Ubie Corporation
Raised: $125.0M (cumulative)
Round:
Funding Date: June 2025
Investors: Google, JAPAN POST CAPITAL, NTT DOCOMO, SEVEN-ELEVEN JAPAN, Japan Finance Corporation, The Shoko Chukin Bank
Company Website: https://ubiehealth.com/
Software Category: HealthTech / AI Diagnostics / Patient Navigation
Source: https://www.prnewswire.com/news-releases/ubie-announces-cumulative-total-funding-of-over-125m-as-us-efforts-target-expansion-into-generative-ai-and-provider-solutions-302491436.html